| Bioactivity | BCR-ABL kinase-IN-3 (example 1) is a potent inhibitor of BCR-ABL that plays an important role in acute myeloid leukemia (AML) research[1]. |
| Name | BCR-ABL kinase-IN-3 |
| CAS | 2699634-21-2 |
| Formula | C35H30FN9O |
| Molar Mass | 611.67 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lee Doohyun, et al. Preparation of 3-((8-((1H-pyrazol-4-yl)amino)imidazo[1,2-a]pyridin-3-yl)ethynyl)-N-phenylbenzamide derivatives for prevention or treatment of cancer. World Intellectual Property Organization, WO2021172931 A1 2021-09-02 |
BCR-ABL kinase-IN-3
CAS: 2699634-21-2 F: C35H30FN9O W: 611.67
BCR-ABL kinase-IN-3 (example 1) is a potent inhibitor of BCR-ABL that plays an important role in acute myeloid leukemia
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.